Sign inJoin waitlistJoin the waitlist

Spyridon Mastroyannis

Associate Program Director, University Hospital · University of Colorado School of Medicine

Credentials: · · · ·

History

University Hospital · University of Colorado School of Medicine
Present
University of Colorado School of Medicine
Present

Gynecologic Oncology
University of Pennsylvania Health System
2019–2022
Hospital of the University of Pennsylvania
2015–2019
George Washington University School of Medicine and Health Sciences
George Washington University Medical School
2011–2015
Yale University (CT) Graduate University of Pennsylvania
2007–2011

Research

Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice
The Journal of Clinical Endocrinology & Metabolism · 2015 · 104 citations
Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · Obstetrics and Gynecology · 2020 · 46 citations
Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes
Gynecologic Oncology · 2018 · 30 citations

Dimitrios Nasioudis
12 papers · 12 as a resident
Emily Ko
12 papers
Ashley Haggerty
8 papers
Robert Giuntoli
7 papers
CS
Constantine Stratakis
5 papers
Mark Morgan
5 papers
Sarah Kim
5 papers
Benjamin Albright
3 papers · 3 as a fellow
Gretchen Glaser
3 papers
Lori Cory
3 papers
Maya Lodish
3 papers
AP
Amy Price
2 papers

Clinical trials

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2025–2030